Our Feature Documentary
We are always looking for new ways to grow our community and tell the stories of those affected by rare diseases. Currently, we are mid-production on a feature-length documentary focused not only on Ryan’s story, but also the stories of families worldwide that CTFAC has helped, and the work we’ve done to advocate for and advance stem cell therapy.
This is the best way to understand our full story, goals, and the drive behind our mission. We are currently still raising funds to finish this project, and all donations will be matched until it is finished.
Our Success with Stem Cell therapy
In 2008, our founder, Ryan Benton was 22 years old and reaching a critical stage in the progression of his terminal disease, Duchenne Muscular Dystrophy. With no viable treatment option available, we placed our last hope in Dr. Riordan’s offer to treat Ryan with Mesenchymal Stem Cell Therapy.
Fortunately, the treatments worked, allowing him to produce dystrophin and reverse the progression of his disease for the first time ever. This made Ryan the first person with DMD to be successfully treated with stem cell therapy, paving the way for others. After 14 years and over 100 treatments later, CTFAC has helped give families around the world hope they can finally believe in!
Our Global Impact
We are based in Wichita, Kansas but we have created a worldwide community that has shared commonalities centered around one thing. Hope.
Connecting with nearly 500 families across the globe
Helping over 150 families access treatments
Launching Clinical trial(s) across the world
Ryan’s success story with stem cell therapy sparked other people with rare, incurable diseases to reach out from around the world. Thus, we have grown a community of families supporting each other as we work to make treatments more accessible to all.
Give the Gift of Hope Today
For as little as $10/month, you can help make a difference in the lives of children across the globe. Your support helps raise awareness and support for those in need of adult stem cell therapy.